| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Special Review |
1 From the Department of Radiology, Duke University Medical Center, Rm 1410, Duke North, Erwin Rd, Durham, NC 27710 (T.G.T., R.E.C.); and the Department of Radiology, Mayo Clinic, Rochester, Minn (E.M.R.). Received September 17, 2002; revision requested November 13; revision received April 14, 2003; accepted May 1. Address correspondence to R.E.C. (e-mail: colem010@mc.duke.edu).
Positron emission tomography (PET) provides metabolic information that has been documented to be useful in patient care. The properties of positron decay permit accurate imaging of the distribution of positron-emitting radiopharmaceuticals. The wide array of positron-emitting radiopharmaceuticals has been used to characterize multiple physiologic and pathologic states. PET is used for characterizing brain disorders such as Alzheimer disease and epilepsy and cardiac disorders such as coronary artery disease and myocardial viability. The neurologic and cardiac applications of PET are not covered in this review. The major utilization of PET clinically is in oncology and consists of imaging the distribution of fluorine 18 fluorodeoxyglucose (FDG). FDG, an analogue of glucose, accumulates in most tumors in a greater amount than it does in normal tissue. FDG PET is being used in diagnosis and follow-up of several malignancies, and the list of articles supporting its use continues to grow. In this review, the physics and instrumentation aspects of PET are described. Many of the clinical applications in oncology are mature and readily covered by third-party payers. Other applications are being used clinically but have not been as carefully evaluated in the literature, and these applications may not be covered by third-party payers. The developing applications of PET are included in this review.
© RSNA, 2004
Index terms: Breast neoplasms, PET, 00.12163 • Gastrointestinal tract, PET, 78.12163 • Head and neck neoplasms, PET, 26.12163, 27.12163 • Lung neoplasms, PET, 68.12163 • Lymphoma, PET, 99.12963 • Melanoma, **.121632 • Review
This article has been cited by other articles:
|
|
 |
|
  S. Belakhlef, C. Church, A. Hays, R. Fraser, and S. Lakhanpal Quantitative Assessment of the Influence of Location, Internal Temperature, Idle Time, and Normalization on the Sensitivity of a Mobile PET/CT Scanner J. Nucl. Med. Technol., September 1, 2008; 36(3): 147 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yamamoto, Y. Nishiyama, R. Kameyama, K. Okano, H. Kashiwagi, A. Deguchi, M. Kaji, and M. Ohkawa Detection of Hepatocellular Carcinoma Using 11C-Choline PET: Comparison with 18F-FDG PET J. Nucl. Med., August 1, 2008; 49(8): 1245 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohno, H. Koyama, Y. Onishi, D. Takenaka, M. Nogami, T. Yoshikawa, S. Matsumoto, Y. Kotani, and K. Sugimura Non-Small Cell Lung Cancer: Whole-Body MR Examination for M-Stage Assessment--Utility for Whole-Body Diffusion-weighted Imaging Compared with Integrated FDG PET/CT Radiology, August 1, 2008; 248(2): 643 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakagawa, M. Yamada, and Y. Suzuki 18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles J. Nucl. Med., July 1, 2008; 49(7): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahner, S. Schirrmacher, W. Brenner, L. Jenicke, C. R. Habermann, N. Avril, and J. Dose-Schwarz Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer Ann. Onc., July 1, 2008; 19(7): 1249 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yoshida, T. Kurokawa, Y. Sawamura, A. Shinagawa, T. Tsujikawa, H. Okazawa, T. Tsuchida, Y. Imamura, N. Suganuma, and F. Kotsuji Comparison of 18F-FDG PET and MRI in Assessment of Uterine Smooth Muscle Tumors J. Nucl. Med., May 1, 2008; 49(5): 708 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Sharkey, H. Karacay, S. Vallabhajosula, W. J. McBride, E. A. Rossi, C.-H. Chang, S. J. Goldsmith, and D. M. Goldenberg Metastatic Human Colonic Carcinoma: Molecular Imaging with Pretargeted SPECT and PET in a Mouse Model Radiology, February 1, 2008; 246(2): 497 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein Imaging in staging of malignant lymphoma: a systematic review Blood, January 15, 2008; 111(2): 504 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Boss, R. V. Olmos, M. Sinaasappel, J. H. Beijnen, and J. H. M. Schellens Application of PET/CT in the Development of Novel Anticancer Drugs Oncologist, January 1, 2008; 13(1): 25 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tatsumi, J. H. Miller, and R. L. Wahl 18F-FDG PET/CT in Evaluating Non-CNS Pediatric Malignancies J. Nucl. Med., December 1, 2007; 48(12): 1923 - 1931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. U. Gerth, K. U. Juergens, U. Dirksen, J. Gerss, O. Schober, and C. Franzius Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors J. Nucl. Med., December 1, 2007; 48(12): 1932 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Voss, S. V. Smith, N. DiBartolo, L. J. McIntosh, E. M. Cyr, A. A. Bonab, J. L. J. Dearling, E. A. Carter, A. J. Fischman, S. T. Treves, et al. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates PNAS, October 30, 2007; 104(44): 17489 - 17493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells J. Cell Biol., October 3, 2007; 178(1): 93 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Kim, J. S. Lee, K. C. Im, S. J. Kim, S.-Y. Kim, D. S. Lee, and D. H. Moon Performance Measurement of the microPET Focus 120 Scanner J. Nucl. Med., September 1, 2007; 48(9): 1527 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamamoto, T. Z. Wong, T. G. Turkington, T. C. Hawk, and R. E. Coleman Head and Neck Cancer: Dedicated FDG PET/CT Protocol for Detection--Phantom and Initial Clinical Studies Radiology, July 1, 2007; 244(1): 263 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cheng, L. Zhang, E. Graves, Z. Xiong, M. Dandekar, X. Chen, and S. S. Gambhir Small-Animal PET of Melanocortin 1 Receptor Expression Using a 18F-Labeled {alpha}-Melanocyte-Stimulating Hormone Analog J. Nucl. Med., June 1, 2007; 48(6): 987 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Elaini, S. K. Shetty, V. M. Chapman, D. V. Sahani, G. W. Boland, A. T. Sweeney, M. M. Maher, J. T. Slattery, P. R. Mueller, and M. A. Blake Improved Detection and Characterization of Adrenal Disease with PET-CT RadioGraphics, May 1, 2007; 27(3): 755 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lindsay, B. A. Siegel, S. R. Tunis, B. E. Hillner, A. F. Shields, B. P. Carey, and R. E. Coleman The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence Development Am. J. Roentgenol., April 1, 2007; 188(4): 1109 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Seierstad, E. Stranden, K. Bjering, M. Evensen, A. Holt, H. M. Michalsen, and O. Wetteland Doses to nuclear technicians in a dedicated PET/CT centre utilising 18F fluorodeoxyglucose (FDG) Radiat Prot Dosimetry, February 1, 2007; 123(2): 246 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Gregoire, K. Haustermans, X. Geets, S. Roels, and M. Lonneux PET-Based Treatment Planning in Radiotherapy: A New Standard? J. Nucl. Med., January 1, 2007; 48(1_suppl): 68S - 77S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Prabhakar, D. V. Sahani, A. J. Fischman, P. R. Mueller, and M. A. Blake Bowel Hot Spots at PET-CT RadioGraphics, January 1, 2007; 27(1): 145 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Veit-Haibach, C. A. Kuehle, T. Beyer, H. Stergar, H. Kuehl, J. Schmidt, G. Borsch, G. Dahmen, J. Barkhausen, A. Bockisch, et al. Diagnostic Accuracy of Colorectal Cancer Staging With Whole-Body PET/CT Colonography JAMA, December 6, 2006; 296(21): 2590 - 2600. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Posther, L. M. McCall, D. H. Harpole Jr., C. E. Reed, J. B. Putnam Jr., V. W. Rusch, and B. A. Siegel Yield of Brain 18F-FDG PET in Evaluating Patients with Potentially Operable Non-Small Cell Lung Cancer J. Nucl. Med., October 1, 2006; 47(10): 1607 - 1611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. McBride, P. Zanzonico, R. M. Sharkey, C. Noren, H. Karacay, E. A. Rossi, M. J. Losman, P.-Y. Brard, C.-H. Chang, S. M. Larson, et al. Bispecific Antibody Pretargeting PET (ImmunoPET) with an 124I-Labeled Hapten-Peptide J. Nucl. Med., October 1, 2006; 47(10): 1678 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Blake, A. Singh, B. N. Setty, J. Slattery, M. Kalra, M. M. Maher, D. V. Sahani, A. J. Fischman, and P. R. Mueller Pearls and Pitfalls in Interpretation of Abdominal and Pelvic PET-CT RadioGraphics, September 1, 2006; 26(5): 1335 - 1353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nie, Q. Li, F. Li, Y. Pu, D. Appelbaum, and K. Doi Integrating PET and CT Information to Improve Diagnostic Accuracy for Lung Nodules: A Semiautomatic Computer-Aided Method J. Nucl. Med., July 1, 2006; 47(7): 1075 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Gatenby, E. T. Gawlinski, A. F. Gmitro, B. Kaylor, and R. J. Gillies Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res., May 15, 2006; 66(10): 5216 - 5223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. KAWAI, E. IKEDA, M. SUGIYAMA, J. MATSUMOTO, T. HIGUCHI, H. ZHANG, N. KHAN, K. TOMIYOSHI, T. INOUE, H. YAMAGUCHI, et al. ENHANCEMENT OF SPLENIC GLUCOSE METABOLISM DURING ACUTE MALARIAL INFECTION: CORRELATION OF FINDINGS OF FDG-PET IMAGING WITH PATHOLOGICAL CHANGES IN A PRIMATE MODEL OF SEVERE HUMAN MALARIA. Am J Trop Med Hyg, March 1, 2006; 74(3): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Zissin, U Metser, H Lerman, G Lievshitz, T Safra, and E Even-Sapir PET-CT findings in surgically transposed ovaries Br. J. Radiol., February 1, 2006; 79(938): 110 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-H. Chou, T.-C. Chang, T.-C. Yen, K.-K. Ng, S. Hsueh, S.-Y. Ma, C.-J. Chang, H.-J. Huang, A. Chao, T.-I Wu, et al. Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before Radical Hysterectomy J. Clin. Oncol., January 1, 2006; 24(1): 123 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A G Schreyer and R Kikinis Combined PET/CT colonography: is this the way forward? Gut, January 1, 2006; 55(1): 10 - 12. [Full Text] [PDF]
|
|
|
|
|
|
P Veit, C Kuhle, T Beyer, H Kuehl, C U Herborn, G Borsch, H Stergar, J Barkhausen, A Bockisch, and G Antoch Whole body positron emission tomography/computed tomography (PET/CT) tumour staging with integrated PET/CT colonography: technical feasibility and first experiences in patients with colorectal cancer Gut, January 1, 2006; 55(1): 68 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lim, M. J. Yun, M.-J. Kim, W. J. Hyung, M.-S. Park, J.-Y. Choi, T.-S. Kim, J. D. Lee, S. H. Noh, and K. W. Kim CT and PET in Stomach Cancer: Preoperative Staging and Monitoring of Response to Therapy RadioGraphics, January 1, 2006; 26(1): 143 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tatsumi, C. Cohade, Y. Nakamoto, E. K. Fishman, and R. L. Wahl Direct Comparison of FDG PET and CT Findings in Patients with Lymphoma: Initial Experience Radiology, December 1, 2005; 237(3): 1038 - 1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sironi, A. Buda, M. Picchio, P. Perego, R. Moreni, A. Pellegrino, M. Colombo, C. Mangioni, C. Messa, and F. Fazio Lymph Node Metastasis in Patients with Clinical Early-Stage Cervical Cancer: Detection with Integrated FDG PET/CT Radiology, December 1, 2005; 238(1): 272 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. MacMahon, J. H. M. Austin, G. Gamsu, C. J. Herold, J. R. Jett, D. P. Naidich, E. F. Patz Jr, and S. J. Swensen Guidelines for Management of Small Pulmonary Nodules Detected on CT Scans: A Statement from the Fleischner Society Radiology, November 1, 2005; 237(2): 395 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Avril, S. Sassen, B. Schmalfeldt, J. Naehrig, S. Rutke, W. A. Weber, M. Werner, H. Graeff, M. Schwaiger, and W. Kuhn Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer J. Clin. Oncol., October 20, 2005; 23(30): 7445 - 7453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Sharkey, H. Karacay, T. M. Cardillo, C.-H. Chang, W. J. McBride, E. A. Rossi, I. D. Horak, and D. M. Goldenberg Improving the Delivery of Radionuclides for Imaging and Therapy of Cancer Using Pretargeting Methods Clin. Cancer Res., October 1, 2005; 11(19): 7109s - 7121s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Even-Sapir Imaging of Malignant Bone Involvement by Morphologic, Scintigraphic, and Hybrid Modalities J. Nucl. Med., August 1, 2005; 46(8): 1356 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dose Schwarz, M. Bader, L. Jenicke, G. Hemminger, F. Janicke, and N. Avril Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential 18F-FDG PET J. Nucl. Med., July 1, 2005; 46(7): 1144 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Enhanced Apoptotic Reaction Correlates with Suppressed Tumor Glucose Utilization After Cytotoxic Chemotherapy: Use of 99mTc-Annexin V, 18F-FDG, and Histologic Evaluation J. Nucl. Med., May 1, 2005; 46(5): 794 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. McCarville, R. Christie, N. C. Daw, S. L. Spunt, and S. C. Kaste PET/CT in the Evaluation of Childhood Sarcomas Am. J. Roentgenol., April 1, 2005; 184(4): 1293 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall Imaging Angiogenesis: Applications and Potential for Drug Development J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Moadel, R. H. Weldon, E. B. Katz, P. Lu, J. Mani, M. Stahl, M. D. Blaufox, R. G. Pestell, M. J. Charron, and E. Dadachova Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-D-Glucose Cancer Res., February 1, 2005; 65(3): 698 - 702. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
